BioSig Technologies, Inc. STEX Corporate — Interest Income Expense Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s corporate — interest income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s corporate — interest income expense net?
- BioSig Technologies, Inc. (STEX) reported corporate — interest income expense net of -$12.2M in Q1 2026.
- What does corporate — interest income expense net mean?
- The net balance of interest income earned on cash and investments versus interest expense paid on debt obligations within the corporate segment. This metric highlights the segment's net financing cost or yield generated from its treasury activities.